Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Genetic variants in the MTHFR are not associated with fatty liver disease
Antonio De Vincentis1, Rosellina Margherita Mancina2, Jussi Pihlajamäki3,4
1Department of Internal Medicine and Geriatrics, University Campus Bio-Medico of Rome, Rome, Italy.
Abstract:
The common missense sequence variants of methylenetetrahydrofolate reductase (MTHFR), rs1801131 (c.A1298C) and rs1801133 (c.C677T), favour the development of hyperhomocysteinemia and diminished DNA methylation. Previous studies, carried out in small series and with suboptimal characterization of the hepatic phenotype, tested the association of these genetic variants with fatty liver disease (FLD), with conflicting results. Here, we assessed the association of rs1801131 and rs1801133 with hepatic phenotype in the Liver Biopsy Cross-Sectional Cohort, a large cohort (n=1375 from Italy and 411 from Finland) of European individuals with suspect FLD associated with dysmetabolism. A total of 1786 subjects were analysed by ordinal regression analyses. The rs1801131 and the rs1801133 variants were not associated with steatosis, inflammation, ballooning or fibrosis. The present study suggests that changes in folate and methionine metabolism resulting from these 2 variants are not associated with a clinically significant impact on FLD in Europeans.
Insights
Common MTHFR gene variants (rs1801131 and rs1801133) do not appear to influence fatty liver disease (FLD) development or severity in European adults. This study found no association with steatosis, inflammation, or fibrosis in a large cohort.
Area of Science:
- Genetics
- Hepatology
- Nutritional Biochemistry
Background:
- Methylenetetrahydrofolate reductase (MTHFR) gene variants (rs1801131 and rs1801133) are linked to hyperhomocysteinemia and altered DNA methylation.
- Previous research on the association between these MTHFR variants and fatty liver disease (FLD) has yielded conflicting results, often due to small sample sizes and limited hepatic phenotype characterization.
Purpose of the Study:
- To investigate the association between MTHFR variants rs1801131 and rs1801133 and the hepatic phenotype in a large cohort of European individuals with suspected FLD.
- To clarify the role of folate and methionine metabolism alterations, influenced by these MTHFR variants, in the pathogenesis of FLD.
Main Methods:
- Analysis of 1786 European individuals from the Liver Biopsy Cross-Sectional Cohort (Italy and Finland) with suspected FLD associated with dysmetabolism.
- Utilized ordinal regression analyses to assess the association between MTHFR variants (rs1801131 and rs1801133) and key hepatic parameters.
Main Results:
- No statistically significant association was found between the rs1801131 and rs1801133 MTHFR variants and the presence of steatosis, inflammation, ballooning, or fibrosis in the liver.
- The study indicates that genetic variations in MTHFR do not significantly impact liver histology in individuals with FLD.
Conclusions:
- The common MTHFR variants rs1801131 and rs1801133 are not associated with clinically significant hepatic phenotypes in European individuals with FLD.
- Alterations in folate and methionine metabolism due to these MTHFR variants do not appear to be a major contributing factor to FLD development or progression in this population.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...